SEPHIENCE 250 mg, oral powder in a sachet 30 sachets
Active ingredients: DL-sepiapterin
Commercialized according to BDPMDispensing in France: Prescription only
Powder30 sachetsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SEPHIENCE 250 mg, poudre orale en sachet
- Pharmaceutical form
- poudre
- Route of administration
- orale
- Presentation description
- 30 sachet(s) polytéréphtalate (PET) PE-aluminium polyéthylène
- Marketing authorisation holder
- PTC THERAPEUTICS INTERNATIONAL (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 27 Apr 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
66347126CIP73031888CIP133400930318881Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SÉPIAPTÉRINEpoudre | 250 mg · un sachet | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.